William P. Feeney

2.6k total citations
45 papers, 1.3k citations indexed

About

William P. Feeney is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Animal Science and Zoology. According to data from OpenAlex, William P. Feeney has authored 45 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Animal Science and Zoology. Recurrent topics in William P. Feeney's work include Pharmacological Effects and Assays (10 papers), Receptor Mechanisms and Signaling (9 papers) and Growth Hormone and Insulin-like Growth Factors (8 papers). William P. Feeney is often cited by papers focused on Pharmacological Effects and Assays (10 papers), Receptor Mechanisms and Signaling (9 papers) and Growth Hormone and Insulin-like Growth Factors (8 papers). William P. Feeney collaborates with scholars based in United States, Japan and New Zealand. William P. Feeney's co-authors include D. Euan MacIntyre, Matthew J. Wyvratt, Ann E. Weber, Michael H. Fisher, Patrick N. Cunningham, Gary J. Hom, Laurie Tota, Margaret A. Cascieri, Mari R. Candelore and Michael J. Forrest and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Virology and Endocrinology.

In The Last Decade

William P. Feeney

45 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William P. Feeney United States	21	361	306	299	227	192	45	1.3k
Thomas Reissmann Germany	19	249 0.7×	204 0.7×	110 0.4×	172 0.8×	261 1.4×	27	1.4k
Phong Nguyen United States	23	539 1.5×	131 0.4×	128 0.4×	200 0.9×	49 0.3×	51	1.2k
Maria L. Webb United States	25	802 2.2×	177 0.6×	152 0.5×	595 2.6×	55 0.3×	93	1.9k
Lisa M. Johnson United States	17	1.0k 2.9×	164 0.5×	283 0.9×	247 1.1×	38 0.2×	51	1.6k
Andrea E. DeBarber United States	23	777 2.2×	372 1.2×	93 0.3×	196 0.9×	45 0.2×	49	1.8k
Stefania Hanau Italy	21	764 2.1×	61 0.2×	97 0.3×	117 0.5×	257 1.3×	61	2.0k
Carlos H. Castro Brazil	21	633 1.8×	573 1.9×	61 0.2×	144 0.6×	50 0.3×	77	1.7k
Yoshiharu Itoh Japan	20	757 2.1×	190 0.6×	202 0.7×	201 0.9×	18 0.1×	56	1.6k
Amanda Kovach Hungary	23	980 2.7×	86 0.3×	59 0.2×	399 1.8×	102 0.5×	98	2.1k
Christoph Boss Switzerland	23	334 0.9×	42 0.1×	243 0.8×	181 0.8×	411 2.1×	53	1.7k

Countries citing papers authored by William P. Feeney

Since Specialization

Citations

This map shows the geographic impact of William P. Feeney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William P. Feeney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William P. Feeney more than expected).

Fields of papers citing papers by William P. Feeney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William P. Feeney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William P. Feeney. The network helps show where William P. Feeney may publish in the future.

Co-authorship network of co-authors of William P. Feeney

This figure shows the co-authorship network connecting the top 25 collaborators of William P. Feeney. A scholar is included among the top collaborators of William P. Feeney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William P. Feeney. William P. Feeney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Feeney, William P., et al.. (2023). Capabilities and limitations of GC–MS and LC-MS/MS for trace detection of organic gunshot residues from skin specimens. Forensic Chemistry. 33. 100471–100471. 8 indexed citations

Feeney, William P., et al.. (2023). A feasibility study of direct analysis in real time-mass spectrometry for screening organic gunshot residues from various substrates. Analytical Methods. 15(36). 4744–4757. 2 indexed citations

Feeney, William P., Arun S. Moorthy, & Edward Sisco. (2022). Spectral trends in GC-EI-MS data obtained from the SWGDRUG mass spectral library and literature: A resource for the identification of unknown compounds. Forensic Chemistry. 31. 100459–100459. 18 indexed citations

Feeney, William P., et al.. (2021). Evaluation of organic and inorganic gunshot residues in various populations using LC-MS/MS. Forensic Chemistry. 27. 100389–100389. 12 indexed citations

Bell, Suzanne & William P. Feeney. (2019). Single shot, single sample, single instrument detection of IGSR and OGSR using LC/MS/MS. Forensic Science International. 299. 215–222. 11 indexed citations

Stearns, Ralph A., Randy R. Miller, Wei Tang, et al.. (2002). The Pharmacokinetics of a Thiazole Benzenesulfonamide β3-Adrenergic Receptor Agonist and Its Analogs in Rats, Dogs, and Monkeys: Improving Oral Bioavailability. Drug Metabolism and Disposition. 30(7). 771–777. 8 indexed citations

Biftu, Tesfaye, Mari R. Candelore, Margaret A. Cascieri, et al.. (2000). Discovery of an orally bioavailable alkyl oxadiazole β3 adrenergic receptor agonist. Bioorganic & Medicinal Chemistry Letters. 10(13). 1427–1429. 15 indexed citations

Candelore, Mari R., Margaret A. Cascieri, Liping Deng, et al.. (2000). Substituted oxazole benzenesulfonamides as potent human β3 adrenergic receptor agonists. Bioorganic & Medicinal Chemistry Letters. 10(14). 1531–1534. 17 indexed citations

Mathvink, Robert J., Mari R. Candelore, Margaret A. Cascieri, et al.. (2000). Potent, selective 3-pyridylethanolamine β3 adrenergic receptor agonists possessing a thiazole benzenesulfonamide pharmacophore. Bioorganic & Medicinal Chemistry Letters. 10(17). 1971–1973. 12 indexed citations

10.

Mathvink, Robert J., Mari R. Candelore, Margaret A. Cascieri, et al.. (2000). Discovery of a Potent, Orally Bioavailable β₃ Adrenergic Receptor Agonist, (R)-N-[4-[2-[[2-Hydroxy-2-(3-pyridinyl)ethyl]amino]ethyl]phenyl]-4-[4-[4-(trifluoromethyl)phenyl]thiazol-2-yl]benzenesulfonamide. Journal of Medicinal Chemistry. 43(21). 3832–3836. 51 indexed citations

11.

Schleim, Klaus D., Thomas M. Jacks, Patrick N. Cunningham, et al.. (1999). Increases in Circulating Insulin-Like Growth Factor I Levels by the Oral Growth Hormone Secretagogue MK-0677 in the Beagle Are Dependent upon Pituitary Mediation¹. Endocrinology. 140(4). 1552–1558. 26 indexed citations

12.

Shih, Thomas L., Mari R. Candelore, Margaret A. Cascieri, et al.. (1999). L-770,644: A potent and selective human β3 adrenergic receptor agonist with improved oral bioavailability. Bioorganic & Medicinal Chemistry Letters. 9(9). 1251–1254. 41 indexed citations

13.

Luffer‐Atlas, Debra, et al.. (1999). Substance P Receptor Antagonist I: Conversion of Phosphoramidate Prodrug after i.v. Administration to Rats and Dogs. Drug Metabolism and Disposition. 27(11). 1367–1373. 19 indexed citations

14.

Ding, Victor, David E. Moller, William P. Feeney, et al.. (1998). Sex Hormone-Binding Globulin Mediates Prostate Androgen Receptor Action via a Novel Signaling Pathway. Endocrinology. 139(1). 213–218. 58 indexed citations

15.

Thompson, Kathryn, S H Vincent, Randall R. Miller, et al.. (1997). Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.. PubMed. 25(10). 1113–8. 37 indexed citations

16.

Hickey, Gerard J., Thomas M. Jacks, Klaus D. Schleim, et al.. (1997). Repeat administration of the GH secretagogue MK-0677 increases and maintains elevated IGF-I levels in beagles. Journal of Endocrinology. 152(2). 183–192. 38 indexed citations

17.

Leung, Kwan, Dosinda Cohn, Randall R. Miller, et al.. (1996). Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.. Drug Metabolism and Disposition. 24(7). 753–760. 8 indexed citations

18.

Jacks, Thomas M., Gerard J. Hickey, J.E. Taylor, et al.. (1994). Effects of acute and repeated intravenous administration of L-692,585, a novel non-peptidyl growth hormone secretagogue, on plasma growth hormone, IGF-1, ACTH, cortisol, prolactin, insulin, and thyroxine levels in beagles. Journal of Endocrinology. 143(2). 399–406. 68 indexed citations

19.

Meurer, Roger, Gail Van Riper, William P. Feeney, et al.. (1993). Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattractant protein 1, human macrophage inflammatory protein 1 alpha, or human interleukin 8.. The Journal of Experimental Medicine. 178(6). 1913–1921. 140 indexed citations

20.

Feeney, William P., et al.. (1982). Semi-automated gas chromatographic method for the assay of tiaramide (RHC 2592) in serum samples. Journal of Chromatography B Biomedical Sciences and Applications. 232(1). 79–84. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact